IGC Pharma
IGC
#10699
Rank
ยฃ19.35 M
Marketcap
ยฃ0.19
Share price
1.59%
Change (1 day)
-40.62%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Market capitalization of IGC Pharma (IGC)

Market cap: ยฃ19.35 Million

As of October 2026 IGC Pharma has a market cap of ยฃ19.35 Million. This makes IGC Pharma the world's 10699th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IGC Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ19.35 M-6.4%
2025ยฃ20.68 M-9.44%
2024ยฃ22.83 M62.96%
2023ยฃ14.01 M0.42%
2022ยฃ13.95 M-62.22%
2021ยฃ36.93 M-24.57%
2020ยฃ48.96 M157.56%
2019ยฃ19.01 M117.72%
2018ยฃ8.73 M-57.98%
2017ยฃ20.78 M222.73%
2016ยฃ6.43 M132.26%
2015ยฃ2.77 M-52.56%
2014ยฃ5.84 M16.16%
2013ยฃ5.03 M0.3%
2012ยฃ5.01 M28.72%
2011ยฃ3.89 M-38.95%
2010ยฃ6.38 M-41.97%
2009ยฃ10.99 M64.7%
2008ยฃ6.67 M-83.91%
2007ยฃ41.5 M-0.39%
2006ยฃ41.66 M

End of Day market cap according to different sources

On Oct 25th, 2026 the market cap of IGC Pharma was reported to be:

ยฃ19.05 Million
by Nasdaq info icon info icon
ยฃ19.05 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sterling Infrastructure
STRL
ยฃ8.26 B 42,607.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
ยฃ1.53 B 7,843.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
ยฃ3.60 B 18,536.97%๐Ÿ‡บ๐Ÿ‡ธ USA